Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Stefanutti

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Cytokine|May 13, 2011
Cytokines profile in serum of homozygous familial hypercholesterolemia is changed by LDL-apheresisC Stefanutti, A Vivenzio, S Di Giacomo, et al.
La Clinica Terapeutica|October 15, 1986
[Effects of the integration of a habitual diet with glucomannan fiber in hypercholesterolemia. A clinical study in familial and sporadic hyperlipoproteinemia with lipo-proteic phenotype IIa and IIb]V Fanelli, F Angelico, C Stefanutti, et al.
La Clinica Terapeutica|October 22, 1998
Effect of L-carnitine on plasma lipoprotein fatty acids pattern in patients with primary hyperlipoproteinemiaC Stefanutti, A Vivenzio, G Lucani, et al.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|January 10, 2002
DALI low-density lipoprotein apheresis in homozygous and heterozygous familial hypercholesterolemic patients using low-dose citrate anticoagulationC Stefanutti, S Di Giacomo, M Di Caro, et al.
La Clinica Terapeutica|December 8, 1998
Pattern of red blood cells and platelets cholesterol and fatty acids in homozygous familial hypercholesterolemic patients treated with LDL-apheresisC Stefanutti, G Lucani, A Vivenzio, et al.
Il Giornale Di Chirurgia|November 13, 2012
The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. UpdatingC Stefanutti, C Morozzi, G Perrone, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 26, 2009
Treatment of symptomatic hyperLp(a)lipidemia with LDL-apheresis vs. usual careC Stefanutti, A Vivenzio, S Di Giacomo, et al.
European Journal of Clinical Investigation|October 13, 2006
Hypercholesterolaemia alters the responses of the plasma lipid profile and inflammatory markers to supplementation of the diet with n-3 polyunsaturated fatty acids from fish oilE Bravo, M Napolitano, I Lopez-Soldado, et al.
Journal of Clinical Apheresis|April 12, 2018
Evolocumab and lipoprotein apheresis combination therapy may have synergic effects to reduce low-density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemia: A case reportM G Zenti, C Stefanutti, V Sanga, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 3, 2016
Individual analysis of patients with HoFH participating in a phase 3 trial with lomitapide: The Italian cohortM Averna, A B Cefalù, C Stefanutti, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Cytokine|May 13, 2011
Cytokines profile in serum of homozygous familial hypercholesterolemia is changed by LDL-apheresisC Stefanutti, A Vivenzio, S Di Giacomo, et al.
La Clinica Terapeutica|October 15, 1986
[Effects of the integration of a habitual diet with glucomannan fiber in hypercholesterolemia. A clinical study in familial and sporadic hyperlipoproteinemia with lipo-proteic phenotype IIa and IIb]V Fanelli, F Angelico, C Stefanutti, et al.
La Clinica Terapeutica|October 22, 1998
Effect of L-carnitine on plasma lipoprotein fatty acids pattern in patients with primary hyperlipoproteinemiaC Stefanutti, A Vivenzio, G Lucani, et al.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|January 10, 2002
DALI low-density lipoprotein apheresis in homozygous and heterozygous familial hypercholesterolemic patients using low-dose citrate anticoagulationC Stefanutti, S Di Giacomo, M Di Caro, et al.
La Clinica Terapeutica|December 8, 1998
Pattern of red blood cells and platelets cholesterol and fatty acids in homozygous familial hypercholesterolemic patients treated with LDL-apheresisC Stefanutti, G Lucani, A Vivenzio, et al.
Il Giornale Di Chirurgia|November 13, 2012
The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. UpdatingC Stefanutti, C Morozzi, G Perrone, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 26, 2009
Treatment of symptomatic hyperLp(a)lipidemia with LDL-apheresis vs. usual careC Stefanutti, A Vivenzio, S Di Giacomo, et al.
European Journal of Clinical Investigation|October 13, 2006
Hypercholesterolaemia alters the responses of the plasma lipid profile and inflammatory markers to supplementation of the diet with n-3 polyunsaturated fatty acids from fish oilE Bravo, M Napolitano, I Lopez-Soldado, et al.
Journal of Clinical Apheresis|April 12, 2018
Evolocumab and lipoprotein apheresis combination therapy may have synergic effects to reduce low-density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemia: A case reportM G Zenti, C Stefanutti, V Sanga, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 3, 2016
Individual analysis of patients with HoFH participating in a phase 3 trial with lomitapide: The Italian cohortM Averna, A B Cefalù, C Stefanutti, et al.
Pageof 4